Genetic and Epigenetic Alterations in Bladder Cancer

  

Epigenetic alterations in urothelial bladder cancer associated with disease outcomes

Francisca Martins Nunes, Joana Dias Apolónio, Anabela Mota‐Pinto, Ricardo Leão

International Journal of Urology.2024; 31(3): 220.     CrossRef

A novel DNA methylation signature revealed GDF6 and RCC1 as potential prognostic biomarkers correlated with cell proliferation in clear cell renal cell carcinoma

Zhijie Xu, Yunfei Wu, Guanan Zhao, Baiye Jin, Peng Jiang

Molecular Biology Reports.2024;[Epub]     CrossRef

Immunohistochemical expressions of EMT markers in pan-RAS–pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients

Kiran Tripathi, Niharika Maurya, Apul Goel, Atin Singhai, Minal Garg

Molecular and Cellular Biochemistry.2023; 478(6): 1169.     CrossRef

Performance of CellDetect for detection of bladder cancer: Comparison with urine cytology and UroVysion

Hila Kreizman Shefer, Ismael Masarwe, Jacob Bejar, Luna Hijazi Naamnih, Keren Gueta-Milshtein, Adel Shalata, Yarin Hadid, Omri Nativ, Ofer Nativ

Urologic Oncology: Seminars and Original Investigations.2023; 41(6): 296.e1.     CrossRef

FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer

Perihan Yagmur Guneri-Sozeri, Gülden Özden-Yılmaz, Asli Kisim, Ece Cakiroglu, Aleyna Eray, Hamdiye Uzuner, Gökhan Karakülah, Devrim Pesen-Okvur, Serif Senturk, Serap Erkek-Ozhan

Communications Biology.2023;[Epub]     CrossRef

H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets

Liliana Burlibasa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, Cosmin Medar, Amelia Petrescu, Viorel Jinga, Ileana Stoica

Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef

Alternative polyadenylation-related genetic variants contribute to bladder cancer risk

Ting Liu, Jingjing Gu, Chuning Li, Mengfan Guo, Lin Yuan, Qiang Lv, Chao Qin, Mulong Du, Haiyan Chu, Hanting Liu, Zhengdong Zhang

The Journal of Biomedical Research.2023; 37(6): 405.     CrossRef

Epigenetic and Immunological Features of Bladder Cancer

Irina Gilyazova, Kadriia Enikeeva, Guzel Rafikova, Evelina Kagirova, Yuliya Sharifyanova, Dilara Asadullina, Valentin Pavlov

International Journal of Molecular Sciences.2023; 24(12): 9854.     CrossRef

Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients

Jialiang Zhu, Ziwen Lu, Mang Ke, Xianguo Cai

International Urology and Nephrology.2022; 54(7): 1505.     CrossRef

Hippo signaling pathway: A comprehensive gene expression profile analysis in breast cancer

Hassan Yousefi, Mahsa Rostamian Delavar, Fatemeh Piroozian, Masoud Baghi, Khoa Nguyen, Thomas Cheng, Cecilia Vittori, David Worthylake, Suresh K. Alahari

Biomedicine & Pharmacotherapy.2022; 151: 113144.     CrossRef

Diagnostic and prognostic potential clustered miRNAs in bladder cancer

Akshay Pramod Ware, Shama Prasada Kabekkodu, Arun Chawla, Bobby Paul, Kapaettu Satyamoorthy

3 Biotech.2022;[Epub]     CrossRef

Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study

Karla B. Peña, Francesc Riu, Anna Hernandez, Carmen Guilarte, Joan Badia, David Parada

Journal of Clinical Medicine.2022; 11(13): 3855.     CrossRef

Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning

Kelly Ward, Mark O Kitchen, Suresh-Jay Mathias, Farhat L Khanim, Richard T. Bryan

Frontiers in Surgery.2022;[Epub]     CrossRef

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer

Zhijie Xu, Hemant Gujar, Guanghou Fu, Hamed Ahmadi, Sumeet Bhanvadia, Daniel J. Weisenberger, Baiye Jin, Parkash S. Gill, Inderbir Gill, Siamak Daneshmand, Kimberly D. Siegmund, Gangning Liang

Frontiers in Oncology.2021;[Epub]     CrossRef

Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder

Kiran Tripathi, Apul Goel, Atin Singhai, Minal Garg

Molecular Biology Reports.2021; 48(3): 2183.     CrossRef

MicroRNA: A signature for cancer progression

Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, Dana K. Sabir, Mohammad Taheri, Soudeh Ghafouri-Fard

Biomedicine & Pharmacotherapy.2021; 138: 111528.     CrossRef

Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples

Paolo Piatti, Yap Ching Chew, Michiko Suwoto, Taikun Yamada, Benjamin Jara, Xi-Yu Jia, Wei Guo, Saum Ghodoussipour, Siamak Daneshmand, Hamed Ahmadi, Jeffrey Rice, Jeffrey Bhasin, Faith Holloway, Yvonne Tsai, Yoshitomo Chihara, Gangning Liang

Clinical Epigenetics.2021;[Epub]     CrossRef

Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer

Alba Loras, Cristina Segovia, José Luis Ruiz-Cerdá

Cancers.2021; 13(11): 2719.     CrossRef

SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis

Ping Tan, Manli Wang, Ailing Zhong, Yiyun Wang, Jiajia Du, Jian Wang, Lu Qi, Zhanying Bi, Peng Zhang, Tianhai Lin, Jiapeng Zhang, Lu Yang, Jingyao Chen, Ping Han, Qiyong Gong, Yu Liu, Chong Chen, Qiang Wei

Oncogene.2021; 40(42): 6081.     CrossRef

Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer

Zhao Zhang, Dongshan Chen, Zeyan Li, Zhao Liu, Lei Yan, Zhonghua Xu

BioMed Research International.2020; 2020: 1.     CrossRef

Tianke Zhang, E Du, Yan Liu, Jun Cheng, Zhihong Zhang, Yong Xu, Shiyong Qi, Yue Chen

International Journal of Nanomedicine.2020; Volume 15: 1457.     CrossRef

Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer

Qilai Long, Ai-Hong Ma, Hongyong Zhang, Zhixiu Cao, Roger Xia, Tzu-Yin Lin, Guru P. Sonpavde, Ralph de Vere White, Jianming Guo, Chong-Xian Pan

Cancer Immunology, Immunotherapy.2020; 69(11): 2305.     CrossRef

MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation

Qisheng Tang, Xue Jiang, Shanjin Ma, Lei Wang, Ruixiao Li, Jianjun Ma

Bioscience Reports.2020;[Epub]     CrossRef

Urinary bladder cancer and its associated factors – An epidemiological overview

Varsha Mishra, Ganesh Balasubramaniam

Indian Journal of Medical Sciences.2020; 73: 239.     CrossRef

Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway

Yi Chen, Ya Peng, Zhipeng Xu, Bo Ge, Xuebao Xiang, Tianyu Zhang, Li Gao, Hailin Shi, Chuang Wang, Jiefu Huang

Pathology - Research and Practice.2019; 215(2): 302.     CrossRef

Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF‐κB‐modulated tumor progression in bladder cancer in vitro and in vivo

Chih‐Hung Chiang, Jing‐Gung Chung, Fei‐Ting Hsu

Environmental Toxicology.2019; 34(6): 679.     CrossRef

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet

Victor G. Martinez, Ester Munera-Maravilla, Alejandra Bernardini, Carolina Rubio, Cristian Suarez-Cabrera, Cristina Segovia, Iris Lodewijk, Marta Dueñas, Mónica Martínez-Fernández, Jesus Maria Paramio

Frontiers in Genetics.2019;[Epub]     CrossRef

Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria

Ilaria Lucca, Sebastian Hofbauer, Andrea Haitel, Martin Susani, Shahrokh Shariat, Tobias Klatte, Michela de Martino

Oncology Letters.2019;[Epub]     CrossRef

lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer

Gang Li, Yang Zhang, Jing Mao, Peng Hu, Qiang Chen, Wei Ding, Rong Pu

Journal of Cellular Biochemistry.2019; 120(10): 18014.     CrossRef

Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine

Jan Gleichenhagen, Christian Arndt, Swaantje Casjens, Carmen Meinig, Holger Gerullis, Irina Raiko, Thomas Brüning, Thorsten Ecke, Georg Johnen

International Journal of Molecular Sciences.2018; 19(1): 226.     CrossRef

Role of Non-Coding RNAs in the Etiology of Bladder Cancer

Caterina Gulìa, Stefano Baldassarra, Fabrizio Signore, Giuliano Rigon, Valerio Pizzuti, Marco Gaffi, Vito Briganti, Alessandro Porrello, Roberto Piergentili

Genes.2017; 8(11): 339.     CrossRef

Differential expression of FGFRs signaling pathway components in bladder cancer: A step toward personalized medicine

Z Ousati Ashtiani, J Tavakkoly-Bazzaz, SA Salami, MR Pourmand, F Mansouri, R Mashahdi, G Pourmand

Balkan Journal of Medical Genetics.2017; 20(2): 75.     CrossRef

Are We Ready to Use the Omics Strategies for Precision Medicine?

Jayoung Kim

International Neurourology Journal.2016; 20(Suppl 2): S65.     CrossRef